JENNISON ASSOCIATES LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 285 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
JENNISON ASSOCIATES LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$597,587
-18.7%
18,899
+4.8%
0.00%0.0%
Q2 2023$735,182
-96.7%
18,028
-94.2%
0.00%
-94.1%
Q1 2022$22,530,000
-81.6%
310,036
-70.1%
0.02%
-78.2%
Q4 2021$122,425,000
-0.7%
1,035,398
+12.7%
0.08%
-2.5%
Q3 2021$123,227,000
-32.5%
918,577
-18.5%
0.08%
-33.9%
Q2 2021$182,553,000
+99.6%
1,127,497
-1.1%
0.12%
+80.6%
Q1 2021$91,480,000
+1005.6%
1,139,871
+649.4%
0.07%
+1016.7%
Q4 2020$8,274,000152,0980.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders